A case-control study on cigarette, alcohol, and coffee consumption preceding Parkinson's disease

Neuroepidemiology

Volumn 22, Issue 5, 2003, Pages 297-304

  Ragonese, P ^a   Salemi, G ^a   Morgante, L ^b   Aridon, P ^a   Epifanio, A ^b   Buffa, D ^a   Scoppa, F ^a   Savettieria, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Alcohol; Cigarette; Coffee; Epidemiology; Parkinson's disease; Risk factors

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CALCULATION; CHRONOLOGY; CIGARETTE SMOKING; COFFEE; COMMUNITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; EVALUATION; EXPOSURE; FEMALE; HUMAN; IDIOPATHIC DISEASE; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARKINSON DISEASE; QUESTIONNAIRE; RANDOMIZATION; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CASE-CONTROL STUDIES; COFFEE; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ODDS RATIO; PARKINSON DISEASE; REGRESSION ANALYSIS; SMOKING;

EID: 0042662816     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071193     Document Type: Article

References (44)

1. Koller W, Vetere-Oldfield B, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C: Environmental risk factors in Parkinson's disease. Neurology 1990;40:1218-1221.
2. Barbeau A: Parkinson's disease: Clinical features and etiopathology; in Vinken PJ, Bruyn GW, Klawans HL (eds): Handbook of Clinical Neurology, series 5, revised. Extrapyramidal Disorders. Amsterdam, Elsevier Science Publishers, 1991, vol 49, pp 87-152.
3. Tanner CM: Epidemiology of movement disorders; in Anderson DW, Schoenberg DG (eds): Neuroepidemiology: A Tribute to Bruce Schoenberg. Boca Raton, CRC Press, 1991, pp 193-216.
4. Ben-Shlomo Y: How far are we in understanding the cause of Parkinson's disease? J Neurol Neurosurg Psychiatry 1996;61:4-16.
5. Seidler A, Hellenbrand W, Robra B-P, Vieregge P, Nischan P, Joerg J, Oertel WH, Schneider E: Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany. Neurology 1996;46:1275-1284.
6. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ: Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997;48:650-658.
7. Liou HH, Tsai MC, Chen CJ, Chang JC, Chen SY, Chen RC: Environmental risk factors and Parkinson's disease: A case-control study in Taiwan. Neurology 1997;48:1583-1588.
8. De Michele G, Filla A, Volpe G, De Marco V, Gogliettino A, Ambrogio G, Marconi R, Castellano AE, Campanella G: Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy. Mov Disord 1996;11:17-23.
9. Bandmann O, Marsden D, Wood NW: Genetic aspects of Parkinson's disease. Mov Disord 1998;13:203-211.
10. Elbaz A, Grigoletto F, Baldereschi M, Breteler MM, Manubens-Bertran JM, Lopez-Pousa S, Dartigues JF, Alperovitch A, Tzourio C, Rocca WA: Familial aggregation of Parkinson's disease. A population-based case-control study in Europe. Neurology 1999;52:1876-1882.
11. Nussbaum RL, Polymeropoulos MH: Genetics of Parkinson's disease. Hum Mol Genet 1997;6:1687-1691.
12. Nefzeger MD, Quadfasel FA, Karl VC: A retrospective study of smoking in Parkinson's disease. Am J Epidemiol 1968;88:149-158.
13. Jiménez-Jiménez FJ, Mateo D, Giménez-Roldan S: Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case-control study. Mov Disord 1992;7:339-344.
14. Morens DM, Grandinetti A, Reed D, White R, Ross GW: Cigarette smoking and protection from Parkinson's disease: False association or etiologic clue? Neurology 1995;45:1041-1051.
15. Tzourio C, Rocca WA, Breteler MM, Baldereschi M, Dartigues JF, Lopez-Pousa S, Manibens-Bertran JM, Alperovitch A: Smoking and Parkinson's disease: An age-dependent risk effect? Neurology 1997;49:1267-1272.
16. Lang AE, Marsden CD, Obeso JA, Parkes JD: Alcohol and Parkinson disease. Ann Neurol 1982;12:254-256.
17. Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA: Smoking, alcohol, and coffee consumption preceding Parkinson's disease. A case-control study. Neurology 2000;55:1350-1358.
18. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung HK, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR: Association of coffee and caffeine intake with the risk of Parkinson's disease. JAMA 2000;283:2674-2679.
19. Ascherio A, Zhang SM, Hernan MA, Kawachi I, Coldiz GA, Speizer FE, Willett WC: Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 2001;50:56-63.
20. Morgante L, Rocca WA, Di Rosa AE, De Domenico P, Grigoletto F, Meneghini F, Reggio A, Savettieri G, Castiglione MG, Patti F, Di Perri R: Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities. Neurology 1992;42:1901-1907.
21. de Rijk MC, Rocca WA, Anderson DW, Melcon MO, Breteler MMB, Maraganore DM: A population perspective on diagnostic criteria for Parkinson's disease. Neurology 1997;48:1277-1281.
22. Mellor CS: Nomogram for calculating mass of alcohol in different beverages. Brit Med J 1970;3:703.
23. Leone M, Bottacchi E, Beghi E, Morgando E, Mutani R, Amedeo G, Cremo R, Gianelli M, Ravegli Ceroni L, Ceroni L: A case-control study on alcohol and seizures: Study design, protocol, and data collection. Ital J Neurol Sci 1997;18:119-124.
24. Schlesselman JJ, Stolley PD: Case-Control Studies. Design, Conduct Analysis. New York, Oxford University Press, 1992.
25. Pagano R, La Vecchia C, Decarli A: Smoking in Italy, 1995. Tumori 1998;84:456-459.
26. Tavani A, Pregnolato A, La Vecchia C, Negri E, Talamini R, Franceschi S: Coffee and tea intake and risk of cancers of the colon and rectum: A study of 3,530 cases and 7,057 controls. Int J Cancer 1997;73:193-197.
27. Di Bari M, Silvestrini G, Chiarlone M, De Alfieri W, Patussi V, Timpanelli M, Pini R, Masotti G, Marchionni N: Features of excessive alcohol drinking in older adults distinctively captured by behavioral and biological screening instruments: An epidemiological study. J Clin Epidemiol 2002;55:41-47.
28. Levy G, Schupf N, Tang M-X, Cote LJ, Louis ED, Mejia V, Stern Y, Marder K: Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 2002;51:722-729.
29. Coffee as a beverage: Its deleterious effects on the nervous system. JAMA 2001;285:384.
30. Todes CJ, Lees AJ: The pre-morbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1985;48:97-100.
31. Paulson GW, Dadmehr N: Is there a premorbid personality typical for Parkinson's disease? Neurology 1991;41(suppl 2):73-76.
32. Menza MA, Golbe LI, Cody RA, Forman NE: Dopamine-related personality traits in Parkinson's disease. Neurology 1993;43:505-508.
33. Fujii C, Harada S, Ohkoshi N, Hayashi A, Yoshizawa K: Cross-cultural traits for personality of patients with Parkinson's disease in Japan. Am J Med Genet 2000;96:1-3.
34. Elbaz A, Manubens-Bertran JM, Baldereschi M, Breteler MM, Grigoletto F, Lopez-Pousa S, Dartigues JF, Alperovitch A, Rocca WA, Tzourio C: Parkinson's disease, smoking, and family history. EUROPARKINSON Study Group. J Neurol 2000;247:793-798.
35. Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D: Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol 1996;144:400-404.
36. Ellenberg JH: Differential postmorbidity mortality in observational studies of risk factors for neurologic disorders. Neuroepidemiology 1994;13:187-194.
37. Vandenbroucke JP, Kok FJ, van' t Bosch G, van den Dungen PJ, van der Heide-Wessel C, van der Heide RM: Coffee drinking and mortality in a 25-year follow-up. Am J Epidemiol 1986;123:359-361.
38. Petrek JA, Sandberg WA, Cole MN, Silberman MS, Collins DC: The inhibitory effect of caffeine on hormone-induced rat breast cancer. Cancer 1985;56:1977-1981.
39. Hennekens CH, Drolette ME, Jesse MJ, Davies JE, Hutchinson GB: Coffee drinking and death due to coronary heart disease. N Engl J Med 1976;294:633-636.
40. 2 receptors in rat striatal membranes. Proc Natl Acad Sci USA 1991;88:7238-7241.
41. 2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci Lett 1996;212:53-56.
42. Fenu S, Cauli O, Morelli M: Cross-sensitization between the motor activating effects of bromocriptine and caffeine: Role of adenosine A (2A) receptors. Behav Brain Res 2000;114:97-105.
43. Popoli P, Caporali MG, Scotti de Carolis A: Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility. J Pharm Pharmacol 1991;43:280-281.
44. 2A receptors modify motor function in MPTP-treated common marmosets. Neuroreport 1998;9:2857-2860.